170 related articles for article (PubMed ID: 36959680)
1. Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells.
Lee BB; Kim D; Kim Y; Han J; Shim YM; Kim DH
Clin Epigenetics; 2023 Mar; 15(1):48. PubMed ID: 36959680
[TBL] [Abstract][Full Text] [Related]
2. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
Sui C; Meng F; Li Y; Jiang Y
J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928
[TBL] [Abstract][Full Text] [Related]
3. Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis.
Jin D; Guo J; Wu Y; Chen W; Du J; Yang L; Wang X; Gong K; Dai J; Miao S; Li X; Su G
J Exp Clin Cancer Res; 2020 Jan; 39(1):6. PubMed ID: 31906986
[TBL] [Abstract][Full Text] [Related]
4. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
Tan M; Wu J; Cai Y
Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
Cheng R; Lu C; Zhang G; Zhang G; Zhao G
Oncol Rep; 2017 Apr; 37(4):2129-2136. PubMed ID: 28350100
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.
Lu L; Liu Q; Wang P; Wu Y; Liu X; Weng C; Fang X; Li B; Cao X; Mao H; Wang L; Guan M; Wang W; Liu G
BMC Cancer; 2019 Mar; 19(1):209. PubMed ID: 30849960
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2.
Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Chu Y
Int J Biol Sci; 2011; 7(6):805-14. PubMed ID: 21750649
[TBL] [Abstract][Full Text] [Related]
9. CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29.
Yang Z; Liu C; Wu H; Xie Y; Gao H; Zhang X
BMC Cancer; 2019 Oct; 19(1):948. PubMed ID: 31615563
[TBL] [Abstract][Full Text] [Related]
10. MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC.
Xie WB; Liang LH; Wu KG; Wang LX; He X; Song C; Wang YQ; Li YH
Cell Physiol Biochem; 2018; 46(2):654-663. PubMed ID: 29617683
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.
Wang L; Qu J; Zhou L; Liao F; Wang J
Cancer Res Treat; 2018 Jul; 50(3):936-949. PubMed ID: 29025258
[TBL] [Abstract][Full Text] [Related]
12. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA.
Du M; Zhang Y; Mao Y; Mou J; Zhao J; Xue Q; Wang D; Huang J; Gao S; Gao Y
Biochem Biophys Res Commun; 2017 Jan; 482(4):582-589. PubMed ID: 27856248
[TBL] [Abstract][Full Text] [Related]
13. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
Tang Q; Li M; Chen L; Bi F; Xia H
Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
[TBL] [Abstract][Full Text] [Related]
14. The mechanism involved in the loss of PTEN expression in NSCLC tumor cells.
Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
Biochem Biophys Res Commun; 2012 Feb; 418(3):547-52. PubMed ID: 22290228
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
16. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines.
Sandhu R; Rivenbark AG; Coleman WB
Int J Oncol; 2012 Aug; 41(2):721-32. PubMed ID: 22664488
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
[TBL] [Abstract][Full Text] [Related]
18. MiR-142 inhibits lung cancer cell proliferation and promotes apoptosis by targeting XIAP.
Wu XB; Li QH; Zhang N; Li M; Li K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7430-7437. PubMed ID: 31539130
[TBL] [Abstract][Full Text] [Related]
19. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
20. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
